Clin2
NCT07179159Likely a fitRecruiting

14-day stomach infection treatment study

HELICOBACTER PYLORI INFECTIONS

Part of Digestive system clinical trials.

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
372 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old
  • You have an active H. pylori infection confirmed by a breath test and at least one other test
  • You have never received treatment to get rid of H. pylori before
  • You do not have serious liver, kidney, or cancer conditions
  • You have no active bleeding in your stomach or intestines
  • You have not had surgery on your upper digestive system

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT06731023Not yet recruiting
Treating Stubborn H. pylori with Tailored Bismuth Quadruple Therapy

This study tests whether a 14-day treatment with bismuth and four drugs, chosen based on lab tests showing which antibiotics still work, can clear an extremely stubborn H. pylori infection that hasn't gone away after at least two prior treatments.

Jinan, Shandong
NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day treatment using two medicines, vonoprazan and minocycline, to get rid of an H. pylori infection in the stomach. It aims to see if this combination is safe and works well, and might be a simpler option for people who haven't been treated for H. pylori before.

NCT07293910Recruiting· Phase 2
Comparing treatments for H. pylori infection

This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.

Tanta
NCT07142798Enrolling by invitation
14-day triple therapy for H. pylori infection

This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.

Kaohsiung City
NCT07750938Not yet recruiting· Phase 4
Optimized treatment for H. pylori infection with stronger acid control

This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.